Table 2. Symptom Dynamics of COVID-19 Survivors According to Disease Severity.
Categories | No. of symptoms | Patients, No. (%) | P value, severe vs nonsevere disease | |||
---|---|---|---|---|---|---|
1-y follow-up | 2-y follow-up | Enrolled patients | Severe disease | Nonsevere disease | ||
Total | NA | NA | 1864 (100.0) | 505 (100.0) | 1359 (100.0) | NA |
Symptoms persista | ≥1 | ≥1 | 224 (12.0) | 89 (17.6) | 135 (9.9) | <.001 |
Symptom reliefb | ≥1 | 0 | 582 (31.2) | 175 (34.7) | 407 (29.9) | .05 |
New-onset symptomsc | 0 | ≥1 | 146 (7.8) | 34 (6.7) | 112 (8.2) | .28 |
No symptomsd | 0 | 0 | 912 (48.9) | 207 (41.0) | 705 (51.9) | <.001 |
Abbreviation: NA, not applicable.
Refers to patients with at least 1 symptom at both 1-year and 2-year follow-up.
Refers to patients with at least 1 symptom at 1-year follow-up but without any symptoms at 2-year follow-up.
Refers to patients without any symptoms at 1-year follow-up, but reported at least 1 symptom at 2-year follow-up, including patients who had a symptom that was reported as a mild problem at year 1, but at 2-year follow-up was reported as moderate or severe problem.
Refers to patients with no symptoms at any follow-up.